Fibrinogen-Binding Peptide ido-PEG9-azide Smiles: CC(=O)N[C@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO

Smiles: CC(=O)N[C@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO

InChi: InChI=1S/C22H23ClN2O8

Verinurad inhibits the transport activity of human URAT1 in a dose-dependent manner

4-dihydropteridin-6-yl)methyl]amino}phenyl)formamido]-4-[(2-{2-[2-(2-aminoethoxy)ethoxy]ethoxy}ethyl)carbamoyl]butanoic acid

5β-Dihydrocortisol can potentiate glucocorticoid activity in raising the intraocular pressure

Fibrinogen-Binding Peptide ido-PEG9-azide Smiles: CC(=O)N[C@H](C=O)[C@@H](O)[C@H](O)[C@H](O)COFibrinogen Binding Peptide (designed by anticomplementarity hypothesis) is a presumptive peptide mimic of the vitronectin binding site on the fibrinogen receptor. Fibrinogen Binding Peptide binds fibrinogen and inhibits both the adhesion of platelets to fibrinogen and platelet aggregation, and also inhibits the adhesion of platelets to vitronectin. Product information CAS Number: 137235 80 4 Molecular Weight: 565. 62 Formula: C25H39N7O8 Chemical Name: